Brief: Scpharmaceuticals Reports Qtrly Net Loss Per Share, Basic And Diluted $0.28
May 16 (Reuters) - scPharmaceuticals Inc SCPH.O :
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.28
* SCPHARMACEUTICALS INC REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
Source text for Eikon: ID:
Further company coverage: SCPH.O
((Reuters.Briefs@thomsonreuters.com;))